Article Sidebar

PDF
Date Published: 26/04/2022
Abstract Views: 464
Views PDF: 544
DOI: https://doi.org/10.51298/vmj.v512i2.2281
Issue
Vol. 512 No. 2 (2022)
Section
Các bài báo
How to Cite
Minh Hoa, H. ., Ngọc Công Khanh, D. ., Hồng Minh, L. ., Thị Tuyết Mai, K. ., & Thị Hà, N. . (2022). COST – EFFECTIVENESS ANALYSIS OF READY-TO-USE INJECTION PREPARATIONS VERSUS CONVENTIONAL RECONSTITUTED ADMIXTURES: A SYSTEMATIC REVIEW. Vietnam Medical Journal, 512(2). https://doi.org/10.51298/vmj.v512i2.2281

COST – EFFECTIVENESS ANALYSIS OF READY-TO-USE INJECTION PREPARATIONS VERSUS CONVENTIONAL RECONSTITUTED ADMIXTURES: A SYSTEMATIC REVIEW

Hoàng Minh Hoa1, Dương Ngọc Công Khanh2, Lê Hồng Minh3, Kiều Thị Tuyết Mai1, Nguyễn Thị Hà2,
1 Hanoi University of Pharmacy
2 Vietnam National University HCMC
3 Health Economics Research and Assessment Center

Main Article Content

Abstract

Backgrounds: Ready-to-use injection preparations are one of the solutions potential to reduce medication errors (ME) related to drugs preparation and administration compared to conventional preparation methods while ensuring the efficacy and safety of drugs. Objectives: To systematically review and assess the health economic evaluations of ready-to-use injection preparations compared to the conventional reconstituted admixtures. Methods: This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement (1). Results: Four eligible studies showed that ready-to-use injection preparations are beneficial in several aspects. They reduced the incidence of ME, thereby reducing ME-related treatment costs, prolonging survival, and improving patients' quality of life. In addition, pre-filled injections may increase the coverage of prophylactic interventions and save more lives. Conclusion: The usage of ready-to-use injections provides both clinical and economic benefits.

Article Details

References

1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10):e1-e34.
2. Fraind Deborah B, Slagle Jason M, Tubbesing Victor A, Hughes Samuel A, Weinger Matthew B. Reengineering Intravenous Drug and Fluid Administration Processes in the Operating Room: Step One: Task Analysis of Existing Processes. Anesthesiology. 2002;97(1):139-47.
3. Adapa RM, Mani V, Murray LJ, Degnan BA, Ercole A, Cadman B, et al. Errors during the preparation of drug infusions: a randomized controlled trial. British journal of anaesthesia. 2012;109(5):729-34.
4. van der Linden P, Douchamps J, Schmitt C,

Forget D. Ready-to-use injection preparations versus conventional reconstituted admixtures: economic evaluation in a real-life setting. PharmacoEconomics. 2002;20(8):529-36.
5. Macias AE, Huertas M, de Leon SP, Munoz JM, Chavez AR, Sifuentes-Osornio J, et al. Contamination of intravenous fluids: a continuing cause of hospital bacteremia. American journal of infection control. 2010;38(3):217-21.
6. Larmené-Beld KHM, Spronk JT, Luttjeboer J, Taxis K, Postma MJ. A Cost Minimization Analysis of Ready-to-Administer Prefilled Sterilized Syringes in a Dutch Hospital. Clinical therapeutics. 2019;41(6):1139-50.
7. Pichon-Riviere A, Glujovsky D, Garay OU, Augustovski F, Ciapponi A, Serpa M, et al. Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis. PloS one. 2015;10(6):e0129044.
8. Rosselli D, Rueda JD, Silva MD, Salcedo J. Economic Evaluation of Four Drug Administration Systems in Intensive Care Units in Colombia. Value in health regional issues. 2014;5:20-4.